ReviewCurrent hematologic malignancy reports2022

Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies.

Ryan J Stubbins et al.PubMed ↗Publisher ↗

No numbers read from the abstract.